• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 21 例尿路结石的原发性高草酸尿症患儿中的 8 种新基因变异。

Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.

机构信息

Department of Pediatric Urology, Xin Hua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.

出版信息

World J Urol. 2019 Aug;37(8):1713-1721. doi: 10.1007/s00345-018-2563-5. Epub 2018 Nov 28.

DOI:10.1007/s00345-018-2563-5
PMID:30488096
Abstract

PURPOSE

We analyzed primary hyperoxaluria (PH) genotype and phenotype in Chinese children. Vitamin B response in the patients with genetically confirmed PH1 was also studied.

METHODS

We, respectively, analyzed 80 children with urinary stones. Sixty-four children were diagnosed with hyperoxaluria. Twenty-one children consented to genetic evaluation (targeted gene panel-based and whole-exome sequencing), and DNA was obtained from the children and both the parents.

RESULTS

PH accounted for 57.1% (12/21) of hyperoxaluria cases. We reported 12 PH cases, including 5 PH1, 1 PH2, and 6 PH3 cases; 2 novel mutations in AGXT and GRHPR each and 4 HOGA1 mutations were identified. The mutations in AGXT and GRHPR were c0.1161C>A and c0.551C>A, and c0.370C>T and c0.864_865delTG, respectively. Four HOGA1 mutations, c0.290G>A, c0.110G>A, c0.554C>T and c0.834_834 + 1delinsTT, were not reported previously. The average urine Ox 24 level in the PH patients was 0.91 mmol/1.73 m. Moreover, the average urine Ox 24 level in the PH1 patients (1.07 mmol/1.73 m) was higher than that in the PH2 and PH3 patients (0.73 mmol/1.73 m and 0.71 mmol/1.73 m, respectively). The eGFR of the PH1 patients (76.86 mL/min) was lower than that of the PH2 and PH3 patients (132 mL/min and 136 mL/min, respectively).

CONCLUSIONS

PH incidence was higher than the reported PH incidence in children with urinary stones. Hence, we suggested that genetic examination was necessary for all the children with hyperoxaluria. These novel mutations broaden the range of known gene mutations in PH.

摘要

目的

我们分析了中国儿童原发性高草酸尿症(PH)的基因型和表型。还研究了经基因确证的 PH1 患者对维生素 B 的反应。

方法

我们分别分析了 80 名结石患儿。其中 64 名被诊断为高草酸尿症。21 名患儿同意进行遗传评估(基于靶向基因panel 和全外显子测序),并从患儿及其父母处获得 DNA。

结果

PH 占高草酸尿症病例的 57.1%(12/21)。我们报告了 12 例 PH 病例,包括 5 例 PH1、1 例 PH2 和 6 例 PH3 病例;发现 2 个 AGXT 和 GRHPR 中的新突变,以及 4 个 HOGA1 突变。AGXT 和 GRHPR 的突变分别为 c0.1161C>A 和 c0.551C>A,以及 c0.370C>T 和 c0.864_865delTG。4 个 HOGA1 突变,c0.290G>A、c0.110G>A、c0.554C>T 和 c0.834_834 + 1delinsTT,以前没有报道过。PH 患者的平均尿 Ox 24 水平为 0.91mmol/1.73m。此外,PH1 患者的平均尿 Ox 24 水平(1.07mmol/1.73m)高于 PH2 和 PH3 患者(分别为 0.73mmol/1.73m 和 0.71mmol/1.73m)。PH1 患者的 eGFR(76.86mL/min)低于 PH2 和 PH3 患者(分别为 132mL/min 和 136mL/min)。

结论

PH 的发病率高于既往报道的结石患儿 PH 发病率,因此我们建议所有高草酸尿症患儿均应进行遗传检查。这些新的突变扩大了 PH 已知基因突变的范围。

相似文献

1
Identification of 8 novel gene variants in primary hyperoxaluria in 21 Chinese children with urinary stones.鉴定 21 例尿路结石的原发性高草酸尿症患儿中的 8 种新基因变异。
World J Urol. 2019 Aug;37(8):1713-1721. doi: 10.1007/s00345-018-2563-5. Epub 2018 Nov 28.
2
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.在中国儿童中发现的 3 型原发性高草酸尿症中 9 种新型 HOGA1 基因突变及不同的临床和生化特征。
Pediatr Nephrol. 2019 Oct;34(10):1785-1790. doi: 10.1007/s00467-019-04279-7. Epub 2019 May 23.
3
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.原发性高草酸尿症的表型-基因型相关性及估计携带者频率
J Am Soc Nephrol. 2015 Oct;26(10):2559-70. doi: 10.1681/ASN.2014070698. Epub 2015 Feb 2.
4
Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.在中国一名原发性3型高草酸尿症患者中鉴定出两种新型HOGA1剪接突变。
Am J Nephrol. 2015;42(1):78-84. doi: 10.1159/000439232.
5
Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.儿童 1 型原发性高草酸尿症:临床和实验室表现及结局。
Pediatr Nephrol. 2023 Aug;38(8):2643-2648. doi: 10.1007/s00467-023-05917-x. Epub 2023 Mar 14.
6
Next-generation sequencing in identification of pathogenic variants in primary hyperoxaluria among 21 Egyptian families: Identification of two novel AGXT gene mutations.在 21 个埃及家庭中,通过下一代测序鉴定原发性高草酸尿症中的致病性变异:鉴定两个新的 AGXT 基因突变。
Mol Genet Genomic Med. 2022 Aug;10(8):e1992. doi: 10.1002/mgg3.1992. Epub 2022 Jun 3.
7
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2.原发性高草酸尿症 3 型与 1 型和 2 型的临床特征比较。
Nephrol Dial Transplant. 2022 Apr 25;37(5):869-875. doi: 10.1093/ndt/gfab027.
8
Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.对临床诊断为原发性高草酸尿症的意大利患者进行的基因检测更新。
J Nephrol. 2017 Apr;30(2):219-225. doi: 10.1007/s40620-016-0287-4. Epub 2016 Mar 5.
9
Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients.在原发性高草酸尿症中鉴定出的四种新变异及21例中国患者的基因型和表型分析
Front Genet. 2023 Apr 17;14:1124745. doi: 10.3389/fgene.2023.1124745. eCollection 2023.
10
Renal function can be impaired in children with primary hyperoxaluria type 3.3型原发性高草酸尿症患儿的肾功能可能受损。
Pediatr Nephrol. 2015 Oct;30(10):1807-13. doi: 10.1007/s00467-015-3090-x. Epub 2015 May 14.

引用本文的文献

1
Mutation Characteristics of Primary Hyperoxaluria in the Chinese Population and Current International Diagnosis and Treatment Status.中国人群原发性高草酸尿症的突变特征及当前国际诊断与治疗现状
Kidney Dis (Basel). 2024 Jun 17;10(4):313-326. doi: 10.1159/000539516. eCollection 2024 Aug.
2
Case series and literature review of primary hyperoxaluria type 1 in Chinese patients.原发性高草酸尿症 1 型中国患者的病例系列和文献复习。
Urolithiasis. 2023 Oct 24;51(1):123. doi: 10.1007/s00240-023-01494-8.
3
HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype-phenotype relationships.

本文引用的文献

1
Tract Sizes in Miniaturized Percutaneous Nephrolithotomy: A Systematic Review from the European Association of Urology Urolithiasis Guidelines Panel.微创经皮肾取石术中的通道大小:欧洲泌尿外科学会结石指南专家组的系统评价。
Eur Urol. 2017 Aug;72(2):220-235. doi: 10.1016/j.eururo.2017.01.046. Epub 2017 Feb 23.
2
Mutational Analysis of Agxt in Tunisian Population with Primary Hyperoxaluria Type 1.突尼斯原发性高草酸尿症1型患者中Agxt基因的突变分析
Ann Hum Genet. 2017 Jan;81(1):1-10. doi: 10.1111/ahg.12178. Epub 2016 Dec 9.
3
Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.
中国人原发性高草酸尿症 3 型患者中 HOGA1 变异体:遗传特征和基因型-表型关系。
World J Urol. 2023 Aug;41(8):2141-2148. doi: 10.1007/s00345-023-04461-5. Epub 2023 Jun 15.
4
Four novel variants identified in primary hyperoxaluria and genotypic and phenotypic analysis in 21 Chinese patients.在原发性高草酸尿症中鉴定出的四种新变异及21例中国患者的基因型和表型分析
Front Genet. 2023 Apr 17;14:1124745. doi: 10.3389/fgene.2023.1124745. eCollection 2023.
5
Next-generation sequencing in identification of pathogenic variants in primary hyperoxaluria among 21 Egyptian families: Identification of two novel AGXT gene mutations.在 21 个埃及家庭中,通过下一代测序鉴定原发性高草酸尿症中的致病性变异:鉴定两个新的 AGXT 基因突变。
Mol Genet Genomic Med. 2022 Aug;10(8):e1992. doi: 10.1002/mgg3.1992. Epub 2022 Jun 3.
6
A novel nonsense variant of the AGXT identified in a Chinese family: special variant research in the Chinese reference genome.在中国的一个家族中发现的 AGXT 的新型无义变异:中国参考基因组中的特殊变异研究。
BMC Nephrol. 2021 Mar 10;22(1):83. doi: 10.1186/s12882-021-02276-3.
肾衰竭前出现的原发性高草酸尿症患者发生终末期肾病的预测因素。
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):119-26. doi: 10.2215/CJN.02810315. Epub 2015 Dec 10.
4
Renal function can be impaired in children with primary hyperoxaluria type 3.3型原发性高草酸尿症患儿的肾功能可能受损。
Pediatr Nephrol. 2015 Oct;30(10):1807-13. doi: 10.1007/s00467-015-3090-x. Epub 2015 May 14.
5
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.原发性高草酸尿症的表型-基因型相关性及估计携带者频率
J Am Soc Nephrol. 2015 Oct;26(10):2559-70. doi: 10.1681/ASN.2014070698. Epub 2015 Feb 2.
6
Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.维生素 B6 在原发性高草酸尿症 I 中的应用:40 年实践后的首次前瞻性试验。
Clin J Am Soc Nephrol. 2014 Mar;9(3):468-77. doi: 10.2215/CJN.06820613. Epub 2014 Jan 2.
7
Primary hyperoxaluria.原发性高草酸尿症
N Engl J Med. 2013 Nov 28;369(22):2163. doi: 10.1056/NEJMc1311606.
8
An update on primary hyperoxaluria.原发性高草酸尿症的最新进展。
Nat Rev Nephrol. 2012 Jun 12;8(8):467-75. doi: 10.1038/nrneph.2012.113.
9
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment.Ⅰ型原发性高草酸尿症:筛查指征和诊断及治疗指导。
Nephrol Dial Transplant. 2012 May;27(5):1729-36. doi: 10.1093/ndt/gfs078.
10
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.该酶 4-羟基-2-氧代戊二酸醛缩酶在原发性高草酸尿症 3 型中缺乏。
Nephrol Dial Transplant. 2012 Aug;27(8):3191-5. doi: 10.1093/ndt/gfs039. Epub 2012 Mar 5.